ATM and neoplasm: When the binding to tumor cells was examined on spheroids that better mimic the tumor structure, a specific binding of rFab’ anti-PD-L1 of 33% and 38% was measured on FaDu and SCC-011 cells, respectively, while 21% specific binding was observed with FITC-ATE (Fig. 6A).